Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01116648
Title Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

peritoneum cancer

Her2-receptor negative breast cancer

fallopian tube cancer

triple-receptor negative breast cancer

ovary epithelial cancer

Therapies

Olaparib

Cediranib + Olaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 United States Details
Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard Fort Wayne Indiana 46804 United States Details
Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne Indiana 46845 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
National Cancer Institute Rockville Maryland 20850 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Massachusetts General Hospital Charlestown Massachusetts 02129 United States Details
Newton-Wellesley Hospital Newton Massachusetts 02462 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field